Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 9,251 | 9,598 | 8,331 | 9,306 | 6,935 |
| Cost of Goods | 2,143 | 2,610 | 1,634 | 2,390 | 1,581 |
| Gross Profit | 7,108 | 6,988 | 6,697 | 6,916 | 5,355 |
| Operating Expenses | 8,459 | 9,179 | 9,177 | 10,700 | 9,132 |
| Operating Income | -1,209 | -1,581 | -1,846 | -3,394 | -3,196 |
| Interest Expense | 75 | 120 | 33 | 29 | 65 |
| Other Income | 12 | 29 | 30 | 48 | -51 |
| Pre-tax Income | -1,272 | -1,672 | -1,849 | -3,376 | -3,312 |
| Income Tax | -4 | 8 | 34 | 2 | -5 |
| Net Income Continuous | -1,276 | -1,679 | -1,883 | -3,369 | -3,316 |
| Net Income Discontinuous | 778 | 739 | 818 | 2,397 | 1,349 |
| Minority Interests | -16 | -22 | -10 | -12 | -13 |
| Net Income | $-482 | $-918 | $-1,056 | $-961 | $-1,954 |
| EPS Basic Total Ops | -0.03 | -0.06 | -0.07 | -0.06 | -0.13 |
| EPS Basic Continuous Ops | -0.08 | -0.11 | -0.12 | -0.21 | -0.22 |
| EPS Basic Discontinuous Ops | 0.05 | 0.05 | 0.05 | 0.15 | 0.09 |
| EPS Diluted Total Ops | -0.03 | -0.06 | -0.07 | -0.06 | -0.13 |
| EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.12 | -0.21 | -0.22 |
| EPS Diluted Discontinuous Ops | 0.05 | 0.05 | 0.05 | 0.15 | 0.09 |
| EBITDA(a) | $-19 | $-398 | $-694 | $-2,269 | $-2,092 |